Reactogenicity of the Messenger <scp>RNA SARS</scp>–<scp>CoV</scp>‐2 Vaccines Associated With Immunogenicity in Patients With Autoimmune and Inflammatory Disease

Monica Yang(University of California, San Francisco), Lianne S. Gensler(University of California, San Francisco), Parakkal Deepak(Washington University in St. Louis), Jane A. O’Halloran(St. Vincent's University Hospital), Alex Carividi(University of California, San Francisco), Wooseob Kim(Korea University), Emanuel Demissie(University of California, San Francisco), Baylee Kinnett, Alem Haile(Washington University in St. Louis), Lily E. McMorrow, Mehrdad Matloubian(University of California, San Francisco), Alia A. El‐Qunni, Ali H. Ellebedy(Washington University in St. Louis), Mary C. Nakamura(University of California, San Francisco), Matthew A. Ciorba, Alfred H.J. Kim(Unknown), Rachel M. Presti(Johns Hopkins University), Kimberly E. Taylor, Patricia Katz(University of California, San Francisco), Niti Pawar(University of California, San Francisco), Michael K. Klebert(Washington University in St. Louis), Katherine Huang(Broad Institute), Michael Paley, Diana Paez(University of California, San Francisco), Rebecca E. Schriefer
Arthritis Care & Research
April 12, 2022
Cited by 8


Related Papers